Mohammad Asif | Pharmaceutical chemistry | Best Researcher Award

Published on by Academic Achievements

Dr. Mohammad Asif | Pharmaceutical chemistry | Best Researcher Award

Professor at Era College of Pharmacy Era University Lucknow, India

Dr. Mohammad Asif is a distinguished researcher and academician specializing in pharmaceutical sciences. He is currently serving as a Professor of Pharmacy at Era Medical College of Pharmacy, Era University, Lucknow, India. With decades of experience in medicinal chemistry, Dr. Asif has made substantial contributions to the synthesis and evaluation of bioactive compounds, focusing on drug development and computational pharmacology.

Profile

ORCID

Education📘

Dr. Asif holds advanced degrees in Pharmacy, with a strong foundation in medicinal chemistry and pharmacology. His academic journey has been enriched by continuous learning and research, enabling him to contribute significantly to innovative drug design.

Experience👨‍🏫

Over the years, Dr. Asif has held several academic and research positions, culminating in his current role as a Professor. His experience spans teaching, mentoring students, and conducting cutting-edge research in medicinal chemistry and pharmacology.

Research Interests🔬

Dr. Asif’s research interests include:

  • Green synthesis and computational studies for drug discovery.
  • Developing bioactive heterocyclic compounds for antimicrobial and antiviral properties.
  • Exploring pharmacological potentials of molecules like pyrazoles, pyrimidines, and oxazines.

Awards and Recognition🏆

Dr. Asif has received numerous accolades for his contributions to pharmaceutical sciences, including recognition for his innovative research on bioactive compounds and his impactful publications in high-impact journals.

Publications📚

Dr. Asif has authored 60 research articles, many of which are widely cited in the scientific community. Below is a selection of his notable works:

Computational Studies and Antimicrobial Activity of 1-(benzo[d]oxazol-2-yl)-3,5-diphenylformazan Derivatives

  • Year: 2024-12
  • Journal: Current Computer-Aided Drug Design
  • DOI: 10.2174/1573409919666230703103135

Diverse Pharmacological Potential of Different Substituted Pyrazole Derivatives

  • Year: 2024-11
  • Journal: Current Organic Synthesis
  • DOI: 10.2174/0115701794260444230925095804

Green Synthetic Methods of Oxazine and Thiazine Scaffolds as Promising Medicinal Compounds: A Mini-review

  • Year: 2024-11
  • Journal: Current Organic Synthesis
  • DOI: 10.2174/1570179420666230811092847

Synthesis, In-Silico Biochemical Properties, and In-Vitro Antimicrobial Activity of Some Farmazans-Sulfonamide Derivatives

  • Year: 2024-11-20
  • Journal: Chemistry & Biodiversity
  • DOI: 10.1002/cbdv.202402488

Towards Antiviral Potential of Biomolecules Derived from Adhatoda vesical as Competent Natural Molecules to Treat COVID-19 Virus Variant

  • Year: 2024-05
  • Journal: Letters in Organic Chemistry
  • DOI: 10.2174/0115701786263427231123103651

An Overview of Various Rifampicin Analogs Against Mycobacterium tuberculosis and Their Drug Interactions

  • Year: 2024-03
  • Journal: Medicinal Chemistry
  • DOI: 10.2174/0115734064260853230926080134

Diverse Pharmacological Potential of Pyridazine Analogs Against Various Diseases

  • Year: 2024-03
  • Journal: Medicinal Chemistry
  • DOI: 10.2174/1573406419666230913102835

Neuropharmacological Potential of Different Piperazine Analogs: A Recent Prospective

  • Year: 2024-01-16
  • Journal: Mini-Reviews in Organic Chemistry
  • DOI: 10.2174/0118756298277743231213065544

An Overview of Diverse Biological Activities of Cinnoline Scaffold

  • Year: 2024-01-04
  • Journal: Mini-Reviews in Organic Chemistry
  • DOI: 10.2174/0118756298265037231119063008

Diverse Pharmacological Potential of Various Substituted Pyrimidine Derivatives

  • Year: 2023-11
  • Journal: Current Organic Chemistry
  • DOI: 10.2174/0113852728266665231101112129

For the complete list of publications, visit Dr. Mohammad Asif’s ORCID.

Conclusion💡

Dr. Mohammad Asif’s illustrious career reflects his dedication to advancing pharmaceutical sciences. His pioneering research on bioactive compounds and green synthesis methods continues to inspire innovation in drug discovery. A passionate educator and prolific author, Dr. Asif remains committed to fostering scientific progress for better healthcare solutions.

Muhammad Rizwan Khan | Drug Design | Best Scholar Award

Published on by Academic Achievements

Dr. Muhammad Rizwan Khan | Drug Design | Best Scholar Award

Lecturer | Sialkot Institute of Science and Technology Sialkot Pakistan | Pakistan 

Strengths for the Award

Muhammad Rizwan Khan exemplifies the qualities sought in a Best Scholar Award recipient. His academic trajectory, including a Pharm-D, M.Phil., and Ph.D. in Pharmaceutical Chemistry, demonstrates a solid foundation in pharmaceutical sciences. His research, focused on the synthesis, characterization, and biological activity of pharmaceutical compounds, particularly Schiff bases of doxycycline, has contributed significantly to the field. His work is well-documented through several publications in reputable journals, indicating a high level of scholarly output. Khan’s professional experience spans roles as a pharmacist, lecturer, and assistant professor, showcasing his ability to bridge practical application with academic theory. His commitment to advancing pharmaceutical sciences through rigorous research and teaching highlights his qualifications for this award.

Areas for Improvement

While Muhammad Rizwan Khan has a strong academic and research background, there are areas where further growth could enhance his profile. Increasing the diversity of his research topics to include emerging areas such as personalized medicine or advanced drug delivery systems could broaden his impact. Expanding his research collaborations beyond national boundaries and contributing to high-impact international journals could increase his global visibility. Additionally, seeking opportunities for interdisciplinary research could lead to innovative solutions and further academic achievements. Enhancing his involvement in international conferences and workshops might also provide greater exposure and opportunities for collaboration.

Short Biography

Muhammad Rizwan Khan is a distinguished researcher and academic in the field of Pharmaceutical Chemistry from Pakistan. With a robust educational background and extensive research experience, he has made significant contributions to the synthesis, characterization, and biological evaluation of pharmaceutical compounds. Currently serving as an Assistant Professor at the Sialkot Institute of Science and Technology, Khan’s career reflects a commitment to advancing pharmaceutical sciences through both research and teaching.

Profile

SCOPUS

Education

Muhammad Rizwan Khan pursued his advanced studies at the Faculty of Pharmacy, the Islamia University of Bahawalpur, where he completed his Doctor of Pharmacy (Pharm-D), followed by an M.Phil. and a Ph.D. in Pharmaceutical Chemistry. His M.Phil. research focused on the “Synthesis, Characterization, and Biological Activity of Schiff Bases of Doxycycline,” achieving a notable CGPA of 3.71/4.00. His Ph.D. research further explores advanced topics in pharmaceutical chemistry, with his thesis currently submitted.

Experience

Khan’s professional journey includes diverse roles in both the pharmaceutical and academic sectors. He began his career as a Professional Sales Officer at OBS Pvt. Ltd., followed by roles as a Community Pharmacist and Pharmacy Manager at Ahmed Pharmacy Vaccine Centre. His academic career includes serving as a Lecturer at Imran Idrees College of Pharmacy and currently as an Assistant Professor at the Sialkot Institute of Science and Technology, where he continues to contribute to pharmaceutical education and research.

Research Interests

Muhammad Rizwan Khan’s research interests are centered on the synthesis and biological evaluation of pharmaceutical compounds. His work includes the development of new drugs and therapeutic agents, with a particular focus on Schiff bases of doxycycline, cancer therapies, and antibacterial agents. His research employs advanced techniques such as FTIR, NMR spectroscopy, and molecular docking to explore novel compounds and their therapeutic potential.

Awards

While specific awards are not detailed in the provided information, Muhammad Rizwan Khan’s consistent publication record and academic achievements underscore his recognition in the field. His contributions to pharmaceutical research reflect a high standard of scholarly excellence, positioning him as a notable candidate for various academic honors and awards.

Publications

Khan MR, Khan MA, Ahmad K, Hamad A, Sajid-ur-Rehman M, Asif HM, Younus M, Kamal Y. Synthesis, Characterization and In Vitro Antibacterial Derivatives of Doxycycline. RADS J Pharm Pharm Sci. 2019;7(4):215-22.
Cited by numerous articles in the field of pharmaceutical sciences.

Rasool, S., Ahmed, H., Malik Uttra, M., Malik Uttra, A., Rizwan Khan, M., Ali Zakir, K., Ali Zaidi, A., Ul Hassan, S., & Saleem, F. Antioxidant and Anti-Cancer Effect of Ethanolic Extract of Citrus Fruits on Hep G2 and MCF-7 Cell Lines. 2021.
Cited in studies related to natural antioxidants and cancer research.

Alshamrani M, Mubeen I, Iqbal MH, Farooq M, Zaman M, Chaudhary MA, Salman O, Butt MH, Salawi A, Khan MR, Almoshari Y. Fast Dissolving Oral Films: An Approach to Co-Load and Deliver the Atorvastatin and Ezetimibe for Better Therapeutic Response. (Submitted).
Currently under review, with potential implications for drug delivery systems.

Mubeen I, Zaman M, Farooq M, Mehmood A, Azeez FK, Rehman W, Akhtar S, Ahmed M, Butt MH, Shamim Q, Khan MR, Adnan S, Ur-Rehman A. Formulation Development of Ezetimibe/Atorvastatin Bilayer Tablets; An In-Vivo and In-Vitro Evaluation. Polymers 2022;14 Under review with implications for advanced drug formulation techniques.

Norfloxacin Derivatives as DNA Gyrase and Urease Inhibitors: Synthesis, Biological Evaluation and Molecular Docking. (In press).
Focuses on novel drug derivatives and their potential therapeutic applications.

Benzoic-D5 Acid as D2 Receptor Agonist in the Treatment of Rotenone-Induced Parkinson’s Disease in Mice. (In press).
Explores potential treatments for Parkinson’s disease using advanced chemical compounds.

Khan MR, Khan MA, Ahmad I, Ahmed J, Ahmed H, Mubeen I, Awan B, Ullah F. Synthesis of Quercetin Derivatives as Cytotoxic Against Breast Cancer MCF-7 Cell Line in Vitro and In Silico Studies. Future Medicinal Chemistry. 2024;1-11.
Addresses novel cancer therapies with a focus on quercetin derivatives.

Insilico Studies, Synthesis, Characterization and In Vitro Studies of Levosulpride Derivatives. (Under review).
Investigates new drug derivatives and their potential clinical applications.

Molecular Docking, Derivatization, Characterization, and Biological Assays of Amantadine. (Accepted).
Covers advanced studies on amantadine and its derivatives for potential therapeutic use.

Conclusion

In conclusion, Muhammad Rizwan Khan’s extensive educational background, combined with his research achievements and professional experience, make him a strong candidate for the Best Scholar Award. His contributions to pharmaceutical chemistry through innovative research and his role in academia highlight his dedication to the field. With continued focus on expanding his research scope and enhancing international collaborations, Khan is well-positioned to make further significant contributions to pharmaceutical sciences and achieve greater recognition in the global academic community.